Skip to main content
POOLBEG PHARMA PLC logo

POOLBEG PHARMA PLC — Investor Relations & Filings

Ticker · POLB ISIN · GB00BKPG7Z60 LEI · 213800UZ8WJLWYHBFL52 IL Manufacturing
Open in API
Filings indexed 160 across all filing types
Latest filing 2023-09-19 Regulatory Filings
Country GB United Kingdom
Listing IL POLB

About POOLBEG PHARMA PLC

https://poolbegpharma.com/

Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company that develops and commercializes medicines for diseases with high unmet medical needs. The company's lead asset, POLB 001, is a treatment designed to prevent Cytokine Release Syndrome (CRS), a severe side effect associated with cancer immunotherapies, with the aim of making these treatments safer and more accessible. Poolbeg is also advancing an oral GLP-1 program for obesity, offering a patient-friendly therapeutic option. The company utilizes an artificial intelligence (AI)-led discovery platform that analyzes data from human challenge trials to identify novel drug targets. This AI-driven approach aims to accelerate target identification, reduce costs, and lower development risks.

Recent filings

Filing Released Lang Actions
Immunomodulator I Patent Opposition Withdrawal
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated September 19, 2023. The content announces a specific corporate event: the withdrawal of a patent opposition ('Immunomodulator I Patent Opposition to be Withdrawn'). This is a material, non-financial announcement disseminated via RNS (Regulatory News Service), which is the primary information provider for the London Stock Exchange. Since the document is a direct announcement of a specific event (patent resolution) and not a general regulatory filing like a 10-K, or an announcement about the release of a larger report (RPA), it fits best under the general 'Regulatory Filings' category (RNS) as it is a standard regulatory news release detailing a legal/IP development. It does not fit the specific definitions for DIRS, DIV, ER, CT, etc.
2023-09-19 English
Interim results for the six months to 30 June 2023
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim results for the six months to 30 June 2023' and contains a detailed CEO statement, business updates, and a reference to the 'Consolidated Statement of Comprehensive Income' (though truncated). It provides substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). It is not merely an announcement of a report, as it contains the actual content and financial highlights. H1 2023
2023-09-13 English
AI led programme identifies influenza drug targets
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 2931E' and contains a date (29 June 2023) followed by company news regarding a successful AI-led program identifying drug targets. The presence of the RNS identifier and the nature of the announcement (a corporate update on scientific progress) strongly suggest this is a regulatory news service release. Since it is a general announcement of corporate progress and does not fit the specific definitions for Earnings Release (ER), Interim Report (IR), or a specific financial filing like 10-K, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements distributed via the London Stock Exchange's news service.
2023-06-29 English
Oral Vaccine Programme Moves Forward
Regulatory Filings Classification · 1% confidence The document is a formal announcement released via the National Storage Mechanism (RNS Number: 5047D) on June 22, 2023. The content details an update on the company's Oral Vaccine Programme, specifically mentioning the advancement following the award of non-dilutive grant funding from the Irish Government's Disruptive Technologies Innovation Fund (DTIF) and the commencement of the validation phase for the encapsulation process. This type of announcement, which provides operational and funding updates but is not a full financial report (like 10-K or IR) or a transcript (CT), fits best under the general category for regulatory news releases. Since it is a specific regulatory announcement detailing progress and funding related to a project, and it is distributed via RNS, it aligns closely with the purpose of a Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it contained financial results, but here it is purely operational/project news. Given the context of RNS distribution and the nature of the update (project milestone achievement), RNS is the most appropriate general regulatory category if a more specific one like CAP (Capital/Financing Update) doesn't fully capture the operational nature of the update. However, since it discusses grant funding and project advancement, it has elements of CAP, but the primary delivery mechanism and format suggest a general regulatory announcement. Comparing the options, it is not a 10-K, AR, CT, ER, or IR. It is an announcement of progress, not a report itself, ruling out RPA based on the 'Menu vs Meal' rule if it were announcing a report. Since it is a specific operational update distributed via RNS, RNS is the best fit as a general regulatory announcement.
2023-06-22 English
Board Appointment
Board/Management Information Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 4071A) on May 24, 2023. The primary subject is the 'Board Appointment' of Brendan Buckley as an Independent Non-Executive Director. This directly relates to changes in senior management/board composition. This aligns perfectly with the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content is not a general regulatory filing but a specific corporate event announcement.
2023-05-24 English
Results of Annual General Meeting
AGM Information Classification · 1% confidence The document is explicitly titled "Results of Annual General Meeting" and states that "at the Annual General Meeting held at 12:00pm today, all resolutions were duly passed." This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including the results announcement. Although it is a short announcement, the content is the result itself, not just an announcement that a report is attached. The RNS Number and the nature of the announcement confirm it is a formal regulatory disclosure related to the AGM.
2023-05-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.